Bibliometric Analysis of Ferroptosis: a Comprehensive Evaluation of Its Contribution to Lung Cancer

Overview

Journal Front Genet

Date 2025 Feb 13

PMID 39944353

Authors

Feifei Yao

Feng Guo

Chuanzhong Sun

Erdong Wang

Hang Wang

Na Li

Affiliations

Soon will be listed here.

Abstract

Objectives: This study employs bibliometric analysis to track evolution and identify trends of key topics in ferroptosis within the context of lung cancer. By identifying emerging research areas, our aim is to provide valuable insights and directions for researchers in this field.

Methods: Relevant papers and reviews on ferroptosis in lung cancer were retrieved from the Web of Science Core Collection database on 5 February 2024. Bibliometric analysis was conducted using CiteSpace 6.2.R3, VOSviewer 1.6.20, R 4.3.0, Bibliometric and Microsoft Excel 2019.

Results: From 2015 to 2020, publications related to ferroptosis in lung cancer were sparse but showed a steady increase. Post-2020, there has been a significant surge, with a 6.4-fold increase observed by 2023. Overall, authors from 4,033 institutions across 42 countries/regions contributed 606 papers published in 262 academic journals. China emerged as the leading contributor, while the United States maintained dominance. Lifang Ma was the most prolific author, with DIXON SJ, YANG WS, and STOCKWELL BR being the most frequently co-cited. Effective communication and collaboration among scholars are lacking. Key journals include Frontiers in Pharmacology for publication output, and Nature and Cell for citation frequency. Research focuses on molecular mechanisms of ferroptosis, including endoplasmic reticulum stress, tumor microenvironment, and autophagy. Therapeutic targets like GPX4, SLC7A11, P53, FSP1, Nrf2, LSH, STYK1/NOK, and ACSL4 are prominent. Traditional Chinese medicine also shows clinical value in ferroptosis research.

Conclusion: Ferroptosis, as a promising research avenue with significant clinical applications in lung cancer, continues to undergo rapid development. The study of iron death in lung cancer will remain a critical research focus in the future.

References

Mao W, Cai Y, Chen D, Jiang G, Xu Y, Chen R . Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non-small cell lung cancer. JCI Insight. 2022; 7(18). PMC: 9675559. DOI: 10.1172/jci.insight.161940. View

Wu S, Zhu C, Tang D, Dou Q, Shen J, Chen X . The role of ferroptosis in lung cancer. Biomark Res. 2021; 9(1):82. PMC: 8572460. DOI: 10.1186/s40364-021-00338-0. View

Niu X, Chen L, Li Y, Hu Z, He F . Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC. Semin Cancer Biol. 2022; 86(Pt 3):273-285. DOI: 10.1016/j.semcancer.2022.03.009. View

Jiao Y, Liu X, Shi J, An J, Yu T, Zou G . Unraveling the interplay of ferroptosis and immune dysregulation in diabetic kidney disease: a comprehensive molecular analysis. Diabetol Metab Syndr. 2024; 16(1):86. PMC: 11032000. DOI: 10.1186/s13098-024-01316-w. View

Wang X, Chen Y, Wang X, Tian H, Wang Y, Jin J . Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11. Cancer Res. 2021; 81(20):5217-5229. PMC: 8530936. DOI: 10.1158/0008-5472.CAN-21-0567. View

Fu F, Wang W, Wu L, Wang W, Huang Z, Huang Y . Inhalable Biomineralized Liposomes for Cyclic Ca-Burst-Centered Endoplasmic Reticulum Stress Enhanced Lung Cancer Ferroptosis Therapy. ACS Nano. 2023; 17(6):5486-5502. DOI: 10.1021/acsnano.2c10830. View

Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L . Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. Adv Sci (Weinh). 2023; 10(33):e2302953. PMC: 10667802. DOI: 10.1002/advs.202302953. View

Wu X, Sui Z, Zhang H, Wang Y, Yu Z . Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma. Front Oncol. 2020; 10:554759. PMC: 7523091. DOI: 10.3389/fonc.2020.554759. View

Wen R, Dong X, Zhuang H, Pang F, Ding S, Li N . Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis. Phytomedicine. 2023; 116:154881. DOI: 10.1016/j.phymed.2023.154881. View

10.

Jelic M, Mandic A, Maricic S, Srdjenovic B . Oxidative stress and its role in cancer. J Cancer Res Ther. 2021; 17(1):22-28. DOI: 10.4103/jcrt.JCRT_862_16. View

11.

Xu X, Cui J, Wang H, Ma L, Zhang X, Guo W . IGF2BP3 is an essential N-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells. Mater Today Bio. 2022; 17:100503. PMC: 9707255. DOI: 10.1016/j.mtbio.2022.100503. View

12.

Xue X, Ma L, Zhang X, Xu X, Guo S, Wang Y . Tumour cells are sensitised to ferroptosis via RB1CC1-mediated transcriptional reprogramming. Clin Transl Med. 2022; 12(2):e747. PMC: 8882240. DOI: 10.1002/ctm2.747. View

13.

Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D . CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020; 19(1):43. PMC: 7045485. DOI: 10.1186/s12943-020-01168-8. View

14.

Li Y, Yang W, Zheng Y, Dai W, Ji J, Wu L . Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis. J Exp Clin Cancer Res. 2023; 42(1):6. PMC: 9817350. DOI: 10.1186/s13046-022-02567-z. View

15.

Chandel A, Goyal A, Ghosh G, Rath G . Recent advances in aerosolised drug delivery. Biomed Pharmacother. 2019; 112:108601. DOI: 10.1016/j.biopha.2019.108601. View

16.

Ma L, Chen T, Zhang X, Miao Y, Tian X, Yu K . The mA reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function. Redox Biol. 2020; 38:101801. PMC: 7691619. DOI: 10.1016/j.redox.2020.101801. View

17.

Zou J, Wang L, Tang H, Liu X, Peng F, Peng C . Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It. Int J Mol Sci. 2021; 22(24). PMC: 8704137. DOI: 10.3390/ijms222413335. View

18.

Dixon S, Olzmann J . The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024; 25(6):424-442. DOI: 10.1038/s41580-024-00703-5. View

19.

Doll S, Proneth B, Tyurina Y, Panzilius E, Kobayashi S, Ingold I . ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2016; 13(1):91-98. PMC: 5610546. DOI: 10.1038/nchembio.2239. View

20.

Wang J, Wong Y, Liao F . What has traditional Chinese medicine delivered for modern medicine?. Expert Rev Mol Med. 2018; 20:e4. DOI: 10.1017/erm.2018.3. View